Resources Contact Us Home
Ultra-high yield intravenous immune globulin preparation

Image Number 3 for United States Patent #7879331.

An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs sodium citrate in two initial fractionation steps, followed by diafiltration to remove sodium citrate.

  Recently Added Patents
Liquid crystal shutter glasses
System and method for passing PLC signals from a first electrical line to a second electrical line
Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging
Encryption using alternate authentication key
Managing imaging of computing devices
Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
Carbonate and carbamate modified forms of glucocorticoids in combination with .beta..sub.2 adrenergic agonists
  Randomly Featured Patents
Voltage controlled oscillator operating with digital controlled loads in a phase lock loop
Medical diagnostic film for soft tissue imaging (i)
Disk drive employing a disk command data structure for tracking a write verify status of a write command
Method of providing lower contact resistance in MOS transistor structures
Electric hair curling iron
Electro-optical device and driving method for the same
Universal strap tightening tool
Method of fabricating a narrow projection such as a write pole extending from a substrate
Estrogen receptors and methods of use
Gas diffuser having varying thickness and nozzle density for semiconductor device fabrication and reaction furnace with gas diffuser